Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now notes that PubMed auto-fills publications and may not be about the study, and the revision is updated to v3.3.2; the prior PubMed disclaimer and v3.2.0 revision were removed.SummaryDifference0.1%

- Check27 days agoChange DetectedThe government funding status notice has been removed from the page. This change does not affect study details, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes to the Study Details page were observed. Any differences appear to be minor formatting or metadata updates that do not affect the study information.SummaryDifference0.3%

- Check71 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedThe page shifts its focus to a broader Ovarian Cancer topic with a new v3.1.0 revision, while removing older, more granular histologic terms and a v3.0.2 tag. This indicates an updated, streamlined content branding rather than adding new substantive details.SummaryDifference0.9%

- Check92 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.